Beam Therapeutics Inc Revenue per Employee (BEAM), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Beam Therapeutics Inc   (NASDAQ: BEAM)
 

Beam Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Beam Therapeutics Inc 's Revenue per employee fell on a trailing twelve month basis to $ 305,352, but the productivity of Beam Therapeutics Inc 's employees remained above the company average.
Within the Healthcare sector Employees of 295 other companies have achieved higher revenue per employee. While Beam Therapeutics Inc 's total ranking has deteriorated compared to the previous quarter from 1558 to 2363. Beam Therapeutics Inc has 511 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BEAM Revenue per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Revenue Change -94.21 % 324.87 % 279.52 % -32.03 % -28.08 %
Sales per Employee (TTM) $ 305,352 320,961 273,470 109,004 117,949
BEAM's Total Ranking # 2363 # 1558 # 1874 # 940 # 1806
Seq. Revenue Change -98.46 % -72.19 % 1076.62 % 14.55 % 13.33 %

BEAM Company Profile >> Back to BEAM Efficiency Comparisons >> Compare BEAM Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 36
Healthcare Sector # 296
Overall Market # 2363

Revenue per Employee Statistics
High Average Low
$ 13,975,538 $ 3,780,763 $ 47
(Dec. 30, 2010)   (Jun 30 2021)



Financial Statements
Beam Therapeutics Inc 's Revenue MRQ $ 0 Millions Visit BEAM's Income Statement
Beam Therapeutics Inc 's Revenues TTM $ 156 Millions Visit BEAM's aggregate revenue growth
What are BEAM's Sales? Visit BEAM's Sales by Segment




Other Ratios
Beam Therapeutics Inc 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
BEAM's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for BEAM's Competitors
Revenue per Employee for BEAM's Suppliers
Revenue per Employee for BEAM's Customers

You may also want to know
BEAM's Sales Growth Rates BEAM's Pe Price to earnings ratio BEAM's Receivables Turnover Ratio BEAM's Stock Quote
BEAM's Net Income Growth Rates BEAM's Ps Price to Sales ratio BEAM's Sales per Employee BEAM's Asset Turnover Ratio
BEAM's Net Margin BEAM's Pb Price to Book ratio BEAM's Financial Strength Ratios BEAM's Dividend Payout Ratio
Date modified: 2026-08-14T08:46:55+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Instil Bio Inc   527,529.41 $ 8.968  Million 17 
Globus Medical Inc   524,155.67 $ 3,144.934  Million 6,000 
10x Genomics Inc   523,400.68 $ 616.566  Million 1,178 
Iradimed Corporation  520,114.23 $ 86.339  Million 166 
Alpha Pro Tech Ltd   505,723.58 $ 62.204  Million 123 
Angiodynamics Inc   502,731.01 $ 317.726  Million 632 
Biofrontera Inc   499,521.74 $ 45.956  Million 92 
Accuray Incorporated  495,467.24 $ 400.833  Million 809 
Resmed Inc   495,001.76 $ 5,628.170  Million 11,370 
Adaptive Biotechnologies Corporation  493,719.55 $ 308.081  Million 624 
Viatris Inc   491,243.33 $ 14,737.300  Million 30,000 
Invivyd Inc   478,401.64 $ 58.365  Million 122 
Maravai Lifesciences Holdings Inc   477,898.85 $ 207.886  Million 435 
Moderna Inc   474,042.55 $ 2,228.000  Million 4,700 
Guardant Health Inc   472,108.94 $ 1,183.105  Million 2,506 
Neuropace Inc   471,866.03 $ 98.620  Million 209 
Skinhealth Systems Inc   471,817.29 $ 289.224  Million 613 
Pelthos Therapeutics Inc   470,695.65 $ 43.304  Million 92 
Inogen Inc   470,523.24 $ 354.304  Million 753 
Regenxbio Inc   470,301.89 $ 174.482  Million 371 
4d Molecular Therapeutics Inc   469,428.57 $ 92.008  Million 196 
Stryker Corp  461,375.00 $ 25,837.000  Million 56,000 
Atara Biotherapeutics Inc   460,857.14 $ 6.452  Million 14 
Glaukos Corp  457,066.73 $ 500.031  Million 1,094 
Treace Medical Concepts Inc   456,237.78 $ 205.307  Million 450 
Medpace Holdings Inc   448,756.13 $ 2,782.288  Million 6,200 
Haemonetics Corporation  447,145.88 $ 1,351.722  Million 3,023 
Nakamoto Inc   445,571.28 $ 28.962  Million 65 
Rockwell Medical inc   444,757.96 $ 69.827  Million 157 
Natera Inc   440,892.02 $ 2,707.077  Million 6,140 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.